News
18h
GlobalData on MSNUroGen concludes enrolment in Phase III trial of UGN-103 for bladder cancerThe trial has enrolled 99 subjects from various centres globally to assess the efficacy and safety of the therapy.
Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia ...
The Bladder Cancer Advocacy Network (BCAN) today announced a Funding Continuity Grant initiative of up to $1 million to provide support for bladder cancer research projects interrupted by gaps in ...
New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...
Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...
Five signs you might have cancer and need a checkup with warning symptoms that should never be ignored or dismissed as stress ...
The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...
5d
Onlymyhealth on MSNFrom Stage 0 to Stage 4: Uncovering Bladder Cancer Stages and TreatmentBladder cancer may be scary but it will help to know that depending on the stage of cancer treatment will help control or ...
Beat bladder cancer with early detection! Expert insights reveal how a multidisciplinary approach can improve treatment outcomes in India. Learn more about effective care.
The FDA designates the TOBY Test as a breakthrough device, revolutionizing bladder cancer detection with a non-invasive, ...
Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results